Status:
UNKNOWN
Therapeutic Effects of Hippotherapy in Children With Prader-Willi Syndrome
Lead Sponsor:
Samsung Medical Center
Collaborating Sponsors:
Samsung Electronics
Conditions:
Prader-Willi Syndrome
Eligibility:
All Genders
42-12 years
Phase:
NA
Brief Summary
This study evaluates the therapeutic effects of hippotherapy in children with Prader-Willi syndrome. Half of children will participate in hippotherapy for 15 weeks (30 minutes per sessions, twice a we...
Detailed Description
This study evaluates the therapeutic effects of hippotherapy in children with Prader-Willi syndrome. Half of children will participate in hippotherapy for 15 weeks (30 minutes per sessions, twice a we...
Eligibility Criteria
Inclusion
- can sit upright on the static surface
- can follow one step command
Exclusion
- body wight \> 35 kg
- serious medical conditions such as cardiac disease, pulmonary disease, uncontrolled epilepsy
- visual impairment, hearing impairment
- bleeding tendency, anticoagulation
- fracture within 6 months, major orthopedic surgery within 1 year
Key Trial Info
Start Date :
August 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03858023
Start Date
August 1 2016
End Date
December 1 2019
Last Update
February 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 06351